To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
15,573 Newest Publications about the topic cancer
rss23-10-2013 | Ata Abbas, William Patterson III, Philippe T. Georgel, Biochemistry and Cell Biology, 2013
Le cancer de la prostate est une maladie grandement affectée par le style de vie, particulièrement la diète, et il est plus fréquent aux États-Unis et dans les pays européens comparativement à l'Asie de sud et de l'est. Parmi les nombreuses causes et facteurs de risques connus, la nutrition ...
01-06-2013 | Masahiko Yabu; Hiroaki Korekane; Koji Hatano; Yasufumi Kaneda; Norio Nonomura; Chihiro Sato; Ken Kitajima; Yasuhide ..., Glycobiology , 2013
We previously reported on the accumulation of a substantial amount of free N-acetylneuraminic acid (Neu5Ac)-containing complex-type N-glycans in human pancreatic cancer cells (Yabu M, Korekane H, Takahashi H, Ohigashi H, Ishikawa O, Miyamoto Y. 2013. Accumulation of free Neu5Ac-containing ...
01-06-2013 | Armen Petrosyan; Pi-Wan Cheng, Glycobiology , 2013
The Golgi apparatus undergoes morphological changes under stress or malignant transformation, but the precise mechanisms are not known. We recently showed that non-muscle myosin IIA (NMIIA) binds to the cytoplasmic tail of Core 2 N-acetylglucosaminyltransferase mucus-type (C2GnT-M) and ...
15-05-2013 | Zhang ZM, Yang XM, Zhang C, Zhang MJ, Li X, Zhang FH, Kang S, Wang SJ, Shan BE, OncoTargets and Therapy, 2013
Zhang ZM, Yang XM, Zhang C, Zhang MJ, Li X, Zhang FH, Kang S, Wang SJ, Shan BE
15-05-2013 | Ueda A, Hosokawa A, Ogawa K, Yoshita H, Ando T, Kajiura S, Fujinami H, Kawai K, Nishikawa J, Tajiri K, Minemura M, S ..., OncoTargets and Therapy, 2013
Ueda A, Hosokawa A, Ogawa K, Yoshita H, Ando T, Kajiura S, Fujinami H, Kawai K, Nishikawa J, Tajiri K, Minemura M, Sugiyama T
13-05-2013 | Author(s): Tim Schäfer , Hendrik Schäfer , Alexander Schmitz , Jörg Ackermann , Norbert Dichter , Claudia Döri ..., Computational Biology and Chemistry, 2013
Publication date: Available online 10 May 2013 Source:Computational Biology and Chemistry Author(s): Tim Schäfer , Hendrik Schäfer , Alexander Schmitz , Jörg Ackermann , Norbert Dichter , Claudia Döring , Sylvia Hartmann , Martin-Leo Hansmann , Ina Koch Hodgkin lymphoma (hl) is ...
12-05-2013 | Author(s): Ruma Dey Ghosh , Kaushik Banerjee , Satyajit Das , Avishek Ganguly , Paramita Chakraborty , Avijit ..., European Journal of Pharmaceutical Science, 2013
Publication date: Available online 9 May 2013 Source:European Journal of Pharmaceutical Sciences Author(s): Ruma Dey Ghosh , Kaushik Banerjee , Satyajit Das , Avishek Ganguly , Paramita Chakraborty , Avijit Sarkar , Mitali Chatterjee , Soumitra K Choudhuri Multidrug resistance ...
11-05-2013 | Zhao‐Shi Bao, Chuan‐Bao Zhang, Hong‐Jun Wang, Wei Yan, Yan‐Wei Liu, Ming‐Yang Li, Wei Zhang, CNS Neuroscience & Therapeutics, 2013
Summary Background The Cancer Genome Atlas (TCGA) has divided patients with glioblastoma multiforme (GBM) into four subtypes based on mRNA expression microarray. The mesenchymal subtype, with a larger proportion, is considered a more lethal one. Clinical outcome prediction is required ...
10-05-2013 | Megan S. Kane, Mark E. Lindsay, Daniel P. Judge, Jemima Barrowman, Colette Ap Rhys, Lisa Simonson, Harry C. Dietz, S ..., American Journal of Medical Genetics Part A, 2013
Abstract Hutchinson–Gilford Progeria Syndrome (HGPS) is a premature aging disorder caused by mutations in LMNA, which encodes the nuclear scaffold proteins lamin A and C. In HGPS and related progerias, processing of prelamin A is blocked at a critical step mediated by the zinc ...
10-05-2013 | Chunguang Yu, Ai‐Yu Gong, Dongqing Chen, Daniel Solelo Leon, Charles YF Young, Xian‐Ming Chen, Molecular Nutrition & Food Research, 2013
Scope Androgen receptor (AR) signaling is critical for all aspects of prostate growth and tumorigenesis. The glucosinolate‐derived phenethyl isothiocyanate (PEITC) has recently been demonstrated to reduce the risk of prostate cancer (PCa) and inhibit PCa cell growth. We previously ...
